Influencing factors of end-of-dose failure in patients with cancer pain after oral oxycodone sustained-release tablets: a retros
![Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy | JACC: Case Reports Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy | JACC: Case Reports](https://www.jacc.org/cms/asset/ac16d764-0c83-4feb-ada7-745e5b464026/fx1.jpg)
Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy | JACC: Case Reports
![The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram](https://www.researchgate.net/publication/259878880/figure/fig1/AS:202657848401940@1425328804772/Study-design-On-the-first-visit-we-changed-the-previous-opioid-drug-to-fentanyl-patch_Q320.jpg)
The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram
![The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram](https://www.researchgate.net/publication/259878880/figure/fig3/AS:202657848401948@1425328804922/The-proportion-of-end-of-dose-failure-on-visit-1-and-visit-2-After-the-use-of-fentanyl_Q640.jpg)
The proportion of end-of-dose failure on visit 1 and visit 2. After the... | Download Scientific Diagram
![CTN | Free Full-Text | Could New Generations of Sensors Reshape the Management of Parkinson's Disease? | HTML CTN | Free Full-Text | Could New Generations of Sensors Reshape the Management of Parkinson's Disease? | HTML](https://www.mdpi.com/ctn/ctn-05-00018/article_deploy/html/images/ctn-05-00018-g001.png)
CTN | Free Full-Text | Could New Generations of Sensors Reshape the Management of Parkinson's Disease? | HTML
![PDF) Management of Breakthrough Pain in Patients with Cancer | Leeroy William and Rod Macleod - Academia.edu PDF) Management of Breakthrough Pain in Patients with Cancer | Leeroy William and Rod Macleod - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44936073/mini_magick20190213-3211-19sl5ws.png?1550081352)
PDF) Management of Breakthrough Pain in Patients with Cancer | Leeroy William and Rod Macleod - Academia.edu
Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use—A health insurance claims analysis | PLOS ONE
![Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial - The American Journal of Medicine Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial - The American Journal of Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/52409180-7f9e-44bf-a843-e069b938cb95/gr1.jpg)
Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial - The American Journal of Medicine
![Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure - Kidney International Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2043393335/2055905132/gr1.gif)
Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure - Kidney International
![Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose | npj Vaccines Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-022-00434-8/MediaObjects/41541_2022_434_Fig1_HTML.png)
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose | npj Vaccines
![Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis | Scientific Reports Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-95787-w/MediaObjects/41598_2021_95787_Fig1_HTML.png)